1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Anticancer Drug Revenue
• 1.4 Market by Type
  • 1.4.1 Global Anticancer Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Targeted Drugs
  • 1.4.3 Cytotoxic Drugs
  • 1.4.4 Hormonal Drugs
• 1.5 Market by Application
  • 1.5.1 Global Anticancer Drug Market Share by Application: 2020 VS 2026
  • 1.5.2 Immunotherapy
  • 1.5.3 Targeted Therapy
  • 1.5.4 Chemotherapy
  • 1.5.5 Hormonal Therapy
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Anticancer Drug Market Perspective (2015-2026)
• 2.2 Global Anticancer Drug Growth Trends by Regions
  • 2.2.1 Anticancer Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Anticancer Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Anticancer Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Anticancer Drug Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Anticancer Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Anticancer Drug Players by Market Size
  • 3.1.1 Global Top Anticancer Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Anticancer Drug Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Anticancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Anticancer Drug Market Concentration Ratio
  • 3.2.1 Global Anticancer Drug Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Anticancer Drug Revenue in 2019
• 3.3 Anticancer Drug Key Players Head office and Area Served
• 3.4 Key Players Anticancer Drug Product Solution and Service
• 3.5 Date of Enter into Anticancer Drug Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Anticancer Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Anticancer Drug Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Anticancer Drug Market Size by Application (2015-2020)
• 5.2 Global Anticancer Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Anticancer Drug Market Size (2015-2020)
• 6.2 Anticancer Drug Key Players in North America (2019-2020)
• 6.3 North America Anticancer Drug Market Size by Type (2015-2020)
• 6.4 North America Anticancer Drug Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Anticancer Drug Market Size (2015-2020)
• 7.2 Anticancer Drug Key Players in Europe (2019-2020)
• 7.3 Europe Anticancer Drug Market Size by Type (2015-2020)
• 7.4 Europe Anticancer Drug Market Size by Application (2015-2020)

8 China

• 8.1 China Anticancer Drug Market Size (2015-2020)
• 8.2 Anticancer Drug Key Players in China (2019-2020)
• 8.3 China Anticancer Drug Market Size by Type (2015-2020)
• 8.4 China Anticancer Drug Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Anticancer Drug Market Size (2015-2020)
• 9.2 Anticancer Drug Key Players in Japan (2019-2020)
• 9.3 Japan Anticancer Drug Market Size by Type (2015-2020)
• 9.4 Japan Anticancer Drug Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Anticancer Drug Market Size (2015-2020)
• 10.2 Anticancer Drug Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Anticancer Drug Market Size by Type (2015-2020)
• 10.4 Southeast Asia Anticancer Drug Market Size by Application (2015-2020)

11 India

• 11.1 India Anticancer Drug Market Size (2015-2020)
• 11.2 Anticancer Drug Key Players in India (2019-2020)
• 11.3 India Anticancer Drug Market Size by Type (2015-2020)
• 11.4 India Anticancer Drug Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Anticancer Drug Market Size (2015-2020)
• 12.2 Anticancer Drug Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Anticancer Drug Market Size by Type (2015-2020)
• 12.4 Central & South America Anticancer Drug Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Roche
  • 13.1.1 Roche Company Details
  • 13.1.2 Roche Business Overview
  • 13.1.3 Roche Anticancer Drug Introduction
  • 13.1.4 Roche Revenue in Anticancer Drug Business (2015-2020))
  • 13.1.5 Roche Recent Development
• 13.2 Celgene
  • 13.2.1 Celgene Company Details
  • 13.2.2 Celgene Business Overview
  • 13.2.3 Celgene Anticancer Drug Introduction
  • 13.2.4 Celgene Revenue in Anticancer Drug Business (2015-2020)
  • 13.2.5 Celgene Recent Development
• 13.3 Pfizer
  • 13.3.1 Pfizer Company Details
  • 13.3.2 Pfizer Business Overview
  • 13.3.3 Pfizer Anticancer Drug Introduction
  • 13.3.4 Pfizer Revenue in Anticancer Drug Business (2015-2020)
  • 13.3.5 Pfizer Recent Development
• 13.4 Bristol-Myers Squibb
  • 13.4.1 Bristol-Myers Squibb Company Details
  • 13.4.2 Bristol-Myers Squibb Business Overview
  • 13.4.3 Bristol-Myers Squibb Anticancer Drug Introduction
  • 13.4.4 Bristol-Myers Squibb Revenue in Anticancer Drug Business (2015-2020)
  • 13.4.5 Bristol-Myers Squibb Recent Development
• 13.5 Novartis
  • 13.5.1 Novartis Company Details
  • 13.5.2 Novartis Business Overview
  • 13.5.3 Novartis Anticancer Drug Introduction
  • 13.5.4 Novartis Revenue in Anticancer Drug Business (2015-2020)
  • 13.5.5 Novartis Recent Development
• 13.6 AstraZeneca
  • 13.6.1 AstraZeneca Company Details
  • 13.6.2 AstraZeneca Business Overview
  • 13.6.3 AstraZeneca Anticancer Drug Introduction
  • 13.6.4 AstraZeneca Revenue in Anticancer Drug Business (2015-2020)
  • 13.6.5 AstraZeneca Recent Development
• 13.7 Teva Pharmaceuticals
  • 13.7.1 Teva Pharmaceuticals Company Details
  • 13.7.2 Teva Pharmaceuticals Business Overview
  • 13.7.3 Teva Pharmaceuticals Anticancer Drug Introduction
  • 13.7.4 Teva Pharmaceuticals Revenue in Anticancer Drug Business (2015-2020)
  • 13.7.5 Teva Pharmaceuticals Recent Development
• 13.8 Bayer
  • 13.8.1 Bayer Company Details
  • 13.8.2 Bayer Business Overview
  • 13.8.3 Bayer Anticancer Drug Introduction
  • 13.8.4 Bayer Revenue in Anticancer Drug Business (2015-2020)
  • 13.8.5 Bayer Recent Development
• 13.9 GlaxoSmithKline
  • 13.9.1 GlaxoSmithKline Company Details
  • 13.9.2 GlaxoSmithKline Business Overview
  • 13.9.3 GlaxoSmithKline Anticancer Drug Introduction
  • 13.9.4 GlaxoSmithKline Revenue in Anticancer Drug Business (2015-2020)
  • 13.9.5 GlaxoSmithKline Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Anticancer Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anticancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Roche
Celgene
Pfizer
Bristol-Myers Squibb
Novartis
AstraZeneca
Teva Pharmaceuticals
Bayer
GlaxoSmithKline

Market segment by Type, the product can be split into
Targeted Drugs
Cytotoxic Drugs
Hormonal Drugs
Market segment by Application, split into
Immunotherapy
Targeted Therapy
Chemotherapy
Hormonal Therapy
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America